node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADIPOQ | ANGPTL4 | ENSSSCP00000046998 | ENSSSCP00000014452 | C1q domain-containing protein. | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | 0.404 |
ADIPOQ | CD34 | ENSSSCP00000046998 | ENSSSCP00000038479 | C1q domain-containing protein. | CD34 molecule. | 0.460 |
ADIPOQ | INS | ENSSSCP00000046998 | ENSSSCP00000044635 | C1q domain-containing protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.915 |
ADIPOQ | LEP | ENSSSCP00000046998 | ENSSSCP00000056831 | C1q domain-containing protein. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.971 |
ADIPOQ | PLIN1 | ENSSSCP00000046998 | ENSSSCP00000065340 | C1q domain-containing protein. | Uncharacterized protein. | 0.901 |
ADIPOQ | PXDN | ENSSSCP00000046998 | ENSSSCP00000022033 | C1q domain-containing protein. | Peroxidasin. | 0.594 |
ANGPTL3 | ANGPTL4 | ENSSSCP00000004131 | ENSSSCP00000014452 | Fibrinogen C-terminal domain-containing protein. | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | 0.920 |
ANGPTL3 | ANGPTL8 | ENSSSCP00000004131 | ENSSSCP00000038848 | Fibrinogen C-terminal domain-containing protein. | Angiopoietin-like protein 8. | 0.991 |
ANGPTL3 | GPIHBP1 | ENSSSCP00000004131 | ENSSSCP00000036748 | Fibrinogen C-terminal domain-containing protein. | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1. | 0.877 |
ANGPTL4 | ADIPOQ | ENSSSCP00000014452 | ENSSSCP00000046998 | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | C1q domain-containing protein. | 0.404 |
ANGPTL4 | ANGPTL3 | ENSSSCP00000014452 | ENSSSCP00000004131 | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | Fibrinogen C-terminal domain-containing protein. | 0.920 |
ANGPTL4 | ANGPTL8 | ENSSSCP00000014452 | ENSSSCP00000038848 | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | Angiopoietin-like protein 8. | 0.968 |
ANGPTL4 | GPIHBP1 | ENSSSCP00000014452 | ENSSSCP00000036748 | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1. | 0.899 |
ANGPTL4 | INS | ENSSSCP00000014452 | ENSSSCP00000044635 | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.411 |
ANGPTL8 | ANGPTL3 | ENSSSCP00000038848 | ENSSSCP00000004131 | Angiopoietin-like protein 8. | Fibrinogen C-terminal domain-containing protein. | 0.991 |
ANGPTL8 | ANGPTL4 | ENSSSCP00000038848 | ENSSSCP00000014452 | Angiopoietin-like protein 8. | Angiopoietin-related protein 4; Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage (By similarity). Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stre [...] | 0.968 |
ANGPTL8 | GPIHBP1 | ENSSSCP00000038848 | ENSSSCP00000036748 | Angiopoietin-like protein 8. | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1. | 0.907 |
CD34 | ADIPOQ | ENSSSCP00000038479 | ENSSSCP00000046998 | CD34 molecule. | C1q domain-containing protein. | 0.460 |
CD34 | INS | ENSSSCP00000038479 | ENSSSCP00000044635 | CD34 molecule. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.756 |
CD34 | LEP | ENSSSCP00000038479 | ENSSSCP00000056831 | CD34 molecule. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.486 |